SEC Form 4 · accession 0001127602-17-029530
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Davide Molho
Officer — Corporate Executive VP
Period of report
Oct 5, 2017
Accepted (ET)
Oct 6, 2017 · 12:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2017 | M | 6,165 | $76.67 | A | 22,714 | D | |
| Common Stock | Oct 5, 2017 | S | 6,165 | $110.00 | D | 16,549 | D | |
| Common Stock | holding | — | — | — | 47,017 | I | By Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $76.67 | Oct 5, 2017 | M | 6,165 | D | Feb 27, 2016 | Feb 27, 2020 | Common Stock | 6,165 | 12,330 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.